These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7591796)

  • 1. Heparin as adjunctive therapy to coronary thrombolysis in acute myocardial infarction.
    Bowlby H; Hisle K; Clifton GD
    Heart Lung; 1995; 24(4):292-304; quiz 304-6. PubMed ID: 7591796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
    Tebbe U; Windeler J; Boesl I; Hoffmann H; Wojcik J; Ashmawy M; Rüdiger Schwarz E; von Loewis P; Rosemeyer P; Hopkins G
    J Am Coll Cardiol; 1995 Aug; 26(2):365-73. PubMed ID: 7608436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive therapy for acute myocardial infarction.
    Alexander J
    Curr Opin Cardiol; 1997 Sep; 12(5):453-8. PubMed ID: 9352172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controversy of heparin therapy as an adjunct to thrombolysis in acute myocardial infarction.
    Chow MS; Wu TS; Chan CL
    DICP; 1991 Jun; 25(6):613-6. PubMed ID: 1877272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction.
    Flaker GC; Bartolozzi J; Davis V; McCabe C; Cannon CP
    Arch Intern Med; 1994 Jul; 154(13):1492-6. PubMed ID: 8018004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarction.
    Prins MH; Hirsh J
    Am J Cardiol; 1991 Jan; 67(3):3A-11A. PubMed ID: 1990783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarifying the conundrum of conjunctive anticoagulation and coronary thrombolysis.
    Sobel BE
    Coron Artery Dis; 1995 Jan; 6(1):83-6. PubMed ID: 7767507
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.
    Wang XK; Zhang Y; Yang CM; Wang Y; Liu GY
    Clin Drug Investig; 2006; 26(6):341-9. PubMed ID: 17163268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
    Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable and circadian response to a fixed high-dose (12 500 IU twice daily) subcutaneous heparin regimen after thrombolytic therapy for acute myocardial infarction.
    Violaris AG; Trudgill NJ; Rowlands L; Gunn J; Tsikaderis D; Campbell S
    Coron Artery Dis; 1994 Mar; 5(3):257-65. PubMed ID: 8199741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
    Arnout J; Simoons M; de Bono D; Rapold HJ; Collen D; Verstraete M
    J Am Coll Cardiol; 1992 Sep; 20(3):513-9. PubMed ID: 1512327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.
    Malcolm AD; Keltai M; Walsh MJ
    Eur Heart J; 1996 Oct; 17(10):1522-31. PubMed ID: 8909909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin management in acute myocardial infarction (AMI).
    Granger CB
    Aust N Z J Med; 1998 Aug; 28(4):541-7. PubMed ID: 9777136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.
    Metz BK; Topol EJ
    Biomed Pharmacother; 1996; 50(6-7):243-53. PubMed ID: 8952863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Menon V; Harrington RA; Hochman JS; Cannon CP; Goodman SD; Wilcox RG; Schünemann HJ; Ohman EM
    Chest; 2004 Sep; 126(3 Suppl):549S-575S. PubMed ID: 15383484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).
    Curtis JP; Alexander JH; Huang Y; Wallentin L; Verheugt FW; Armstrong PW; Krumholz HM; Van de Werf F; Danays T; Cheeks M; Granger CB;
    Am J Cardiol; 2004 Aug; 94(3):279-83. PubMed ID: 15276088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis in the management of acute myocardial infarction. Current status and future perspectives.
    Verheugt F
    Rev Port Cardiol; 1998 Dec; 17(12):959-65. PubMed ID: 9973856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.
    Jang IK; Brown DF; Giugliano RP; Anderson HV; Losordo D; Nicolau JC; Dutra OP; Bazzino O; Viamonte VM; Norbady R; Liprandi AS; Massey TJ; Dinsmore R; Schwarz RP
    J Am Coll Cardiol; 1999 Jun; 33(7):1879-85. PubMed ID: 10362188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.